Werbung
Werbung

BCDA

BCDA logo

BioCardia, Inc. Common Stock

1.41
USD
Gesponsert
+0.09
+6.82%
09. Jan., 15:40 UTC -5
Geschlossen
exchange

Nach-Markt

1.43

+0.02
+1.42%

BCDA Ergebnisberichte

Positives Überraschungsverhältnis

BCDA übertreffen die 16 der letzten 23Schätzungen.

70%

Nächster Bericht

Datum des nächsten Berichts
24. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.17
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/
-29.17%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/
-32.00%

BioCardia, Inc. Common Stock earnings per share and revenue

On 12. Nov. 2025, BCDA reported earnings of -0.24 USD per share (EPS) for Q3 25, missing the estimate of -0.23 USD, resulting in a -2.30% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -3.08% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.17 USD, with revenue projected to reach -- USD, implying an decrease of -29.17% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
For Q3 2025, BioCardia, Inc. Common Stock reported EPS of -$0.24, missing estimates by -2.3%, and revenue of $0.00, 0% as expectations.
The stock price moved down -3.08%, changed from $1.30 before the earnings release to $1.26 the day after.
The next earning report is scheduled for 24. März 2026.
Based on 4 analysts, BioCardia, Inc. Common Stock is expected to report EPS of -$0.17 and revenue of -- for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung